Guidelines

How to become a leader: Part 2
In the second article in this series on leadership we look at the importance of increasing your visibility by getting involved in advocacy.
The case of the kidney killers
When we swear to do no harm, it’s not only in our day-to-day interactions, writes, Dr. Yuan-Innes. We have to recognize systemic biases, not only in how we act but also those baked into our tools.

Better than real-life clinical rotations? How one university is using ChatGPT to fill the missing pieces in pharmacist training

The success of the anticoagulation therapy management program at the University of the Waterloo could soon open the door to similar AI-powered virtual training in high-demand areas such as hypertension management.
Where to start?

We do not want to stop medications that are safely helping to treat symptoms, but we could think about ‘legacy prescriptions’ which people may have been taking for many years without re-evaluation.
Cannabis used by youth under 18 increases risk for schizophrenia

Use linked to changes in grey and white matter in the brain.
QUIZ: How much do you know about transient ischemic attacks?

Test your knowledge of the assessment and management of TIAs.
NAPRA removes ephedrine and pseudoephedrine from National Drug Schedules

The move means that the National Association of Pharmacy Regulatory Authorities has now removed all products with Natural Product Number or Drug Identification Number-Homeopathic Medicine from the National Drug Schedules.
Executives of U.S. telehealth company accused of fraud that gave easy access to addictive Adderall drug

The actions of Done Global are alleged to have contributed to the ongoing shortage of ADHD medication.
Poll: Should poverty be treated as a health condition?

See what your colleagues say. Take our weekly doctor poll.
Specialty medications: the AQPP requests class action suit against some of its members

In its appeal, the AQPP denounces an ‘opaque ecosystem for the distribution of specialty drugs’ which would harm the financial health of community pharmacies and patient safety.

How to become a leader: Part 2

The case of the kidney killers

Better than real-life clinical rotations? How one university is using ChatGPT to fill the missing pieces in pharmacist training

Where to start?

Cannabis used by youth under 18 increases risk for schizophrenia

QUIZ: How much do you know about transient ischemic attacks?

NAPRA removes ephedrine and pseudoephedrine from National Drug Schedules

Executives of U.S. telehealth company accused of fraud that gave easy access to addictive Adderall drug

Poll: Should poverty be treated as a health condition?

Specialty medications: the AQPP requests class action suit against some of its members